| Title |
25 Years of Contrast-Enhanced MRI: Developments, Current Challenges and Future Perspectives
|
|---|---|
| Published in |
Advances in Therapy, January 2016
|
| DOI | 10.1007/s12325-015-0275-4 |
| Pubmed ID | |
| Authors |
Jessica Lohrke, Thomas Frenzel, Jan Endrikat, Filipe Caseiro Alves, Thomas M. Grist, Meng Law, Jeong Min Lee, Tim Leiner, Kun-Cheng Li, Konstantin Nikolaou, Martin R. Prince, Hans H. Schild, Jeffrey C. Weinreb, Kohki Yoshikawa, Hubertus Pietsch |
| Abstract |
In 1988, the first contrast agent specifically designed for magnetic resonance imaging (MRI), gadopentetate dimeglumine (Magnevist(®)), became available for clinical use. Since then, a plethora of studies have investigated the potential of MRI contrast agents for diagnostic imaging across the body, including the central nervous system, heart and circulation, breast, lungs, the gastrointestinal, genitourinary, musculoskeletal and lymphatic systems, and even the skin. Today, after 25 years of contrast-enhanced (CE-) MRI in clinical practice, the utility of this diagnostic imaging modality has expanded beyond initial expectations to become an essential tool for disease diagnosis and management worldwide. CE-MRI continues to evolve, with new techniques, advanced technologies, and novel contrast agents bringing exciting opportunities for more sensitive, targeted imaging and improved patient management, along with associated clinical challenges. This review aims to provide an overview on the history of MRI and contrast media development, to highlight certain key advances in the clinical development of CE-MRI, to outline current technical trends and clinical challenges, and to suggest some important future perspectives. Bayer HealthCare. |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 3 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 33% |
| Practitioners (doctors, other healthcare professionals) | 1 | 33% |
| Science communicators (journalists, bloggers, editors) | 1 | 33% |
Mendeley readers
The data shown below were compiled from readership statistics for 462 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | <1% |
| Norway | 1 | <1% |
| Unknown | 459 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 79 | 17% |
| Student > Master | 69 | 15% |
| Researcher | 50 | 11% |
| Student > Bachelor | 47 | 10% |
| Other | 31 | 7% |
| Other | 61 | 13% |
| Unknown | 125 | 27% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 93 | 20% |
| Chemistry | 83 | 18% |
| Engineering | 27 | 6% |
| Physics and Astronomy | 18 | 4% |
| Nursing and Health Professions | 16 | 3% |
| Other | 84 | 18% |
| Unknown | 141 | 31% |
Attention Score in Context
This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 February 2024.
All research outputs
#6,543,977
of 24,225,722 outputs
Outputs from Advances in Therapy
#583
of 2,492 outputs
Outputs of similar age
#101,594
of 404,838 outputs
Outputs of similar age from Advances in Therapy
#9
of 38 outputs
Altmetric has tracked 24,225,722 research outputs across all sources so far. This one has received more attention than most of these and is in the 72nd percentile.
So far Altmetric has tracked 2,492 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.3. This one has done well, scoring higher than 76% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 404,838 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.
We're also able to compare this research output to 38 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 76% of its contemporaries.